Seven dose-limiting toxicities occurred across all participants. At the 1.5 mg/kg dose of zilovertamab vedotin plus R-GemOx, one participant had Grade 4 febrile neutropenia. At the 1.75 mg/kg dose, ...

"In the Phase 2 portion of the waveLINE-003 trial, the 1.75 mg/kg dose of zilovertamab vedotin with rituximab, gemcitabine and oxaliplatin demonstrated a promising response rate, complete response ...

Background Clopidogrel bisulfate and aspirin are routinely administered as dual antiplatelet agents for many neurointerventional procedures, especially for intravascular stent placement. Many patients ...

Each study period lasted 6 days including administration of loading and maintenance doses of AT-10 (40 mg/10 mg) or clopidogrel (300 mg/75 mg). ... AT-10 (2-oxo-clopidogrel bisulfate) is a novel ...

The only exception, which contemplates the elderly, refers to patients aged over 75 years undergoing fibrinolytic therapy, for whom only the dose of 75 mg clopidogrel is recommended, with no ...

Based on data, 1.75 mg/kg dose established as recommended dose for Phase 3 trial of this investigational antibody-drug conjugate December 08, 2024 03:00 PM Eastern Standard Time ...

The indobufen group was treated with indobufen and clopidogrel (oral indobufen tablets 100 mg twice daily, clopidogrel bisulfate tablets 75 mg daily). Data collection Observation indicators included ...

JAMP Pharma Corporation and Angita (AG) Pharma Inc. are recalling all lots of JAMP-Clopidogrel and AG-Clopidogrel 75 mg tablets as some tablets may weigh less or more than they should, meaning ...

OTTAWA, ON, Sept. 5, 2024 /CNW/ -. Summary. Products: JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets Issue: Health products – Product safety What to do: If you are taking the affected ...